Screener
Evommune
EVMNEvommune is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Luis C. Pena, with a market cap of $511.0M.
$510.99M-7.7%
We’re still putting together Evommune’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Evommune up the queue, and we’ll analyze its filings next.
Earnings
Next report
Oct 16, 2026 (in 2 months)Revenue estimate$500.0K
EPS estimate-$0.82
Profile
CountryUnited States of America
Listed2025
Employees48.0
CEOLuis C. Pena
SectorHealthcare
IndustryBiotechnology
Websiteevommune.com
FilingsSEC EDGAR